ERBB2 and neoplasm: ERα expression correlates with expression of progesterone receptor (PR), lower tumor grade, response to endocrine therapy, lower grade of aneuploidy, less frequent overexpression of HER-2 oncogene, bone metastases and slower rate of tumor recurrence [2].